ClinicalTrials.gov
public full text
Public Domain
Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)
This study is performed to confirm the optimal dose for THR (total hip replacement).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacement#1229004
- Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate#1228187
- Apixaban or Enoxaparin After Head and Neck Cancer Surgery#1161504
- KINCISE™ Surgical Automated System in Total Hip Arthroplasty (THA)#1352866
- A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis#1211954
Record · ID 1182516
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive